Mohit D Gandhi

A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects

P. Loupe, E. Aycardi, O. Spiegelstein, 2018, Cephalalgia : an international journal of headache.

11th European Headache Federation Congress jointly with 31st Congress of the Italian Society for the Study of Headaches

E. Aycardi, O. Cohen‐Barak, P. Yeung, 2017, The Journal of Headache and Pain.